Ученые разработали ПО для определения выживаемости пациентов с раком легких

Experts in mathematical modeling at Sechenov University have applied Oncomonitor software to forecast disease progression in patients with non-small cell lung cancer (NSCLC) depending on the stage of the disease and the types of therapy regimens used.

The new method is based on meta-analysis combined with survival models, which the program can use to make predictions, the university said.

The model takes into account the stage of the disease, the presence or absence of certain mutations or biomarkers...